Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

Membrane proteins constitute about one third of the proteome in most organisms, perform critical cellular and physiological functions and represent over 60% of current drug targets in humans 1.

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...

Classic cybersecurity tools are nearly powerless against semantic attacks. Signature detection, hashing, and code audits all depend on identifying explicit changes in code or data, but meaning-level ...

The Ault PENT1040A/B/C/D family of high power injectors target PoE, gigabit-compatible applications (10/100/1,000-Mbit/s data rates) with up to 40–W power. They provide power to devices through RJ45 ...

The UK’s National Cyber Security Centre (NCSC) is warning organisations to be wary of the imminent cyber risks associated with the integration of Large Language Models (LLMs) — such as ChatGPT — into ...

In a 2023 report, McKinsey & Company projected 35 GW of new power will be needed for data centers in the U.S. by 2030. This forecast doubled the required power consumption from data servers, up from ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced they will give one oral ...